Isomorphic Labs secures $5B Series C to advance AI-discovered drugs into human trials
DeepMind spinout Isomorphic Labs closed a $5B funding round led by Greenoaks and Sequoia, valuing the AI drug-discovery company at $50B as it moves preclinical candidates toward clinical development.
Radical Numerics Launches AI Model to Detect AI-Generated Pathogens
A biosecurity startup unveils Omnii Defense, an edge model that identifies engineered biological threats without internet connectivity.
Potential Sciences Aims to Automate Drug Discovery With Physics-Guided AI
A UK startup is training AI models on simulated molecular interactions to predict effective drugs faster and cheaper than traditional lab experimentation.
OpenAI Acquires Orchestra Bio to Expand Life Sciences AI Capabilities
OpenAI has acquired Orchestra Bio, an AI biotech software startup, to accelerate its Rosalind life sciences research platform and compete in pharmaceutical automation.